tag:blogger.com,1999:blog-4241416962008169508.post1574750989480593255..comments2024-03-29T06:40:19.495-04:00Comments on Just A Life Sciences Blog...: Will Roche/Genetech Pivot Hard, Drive The Lane -- And Snag "First Mover" Anti-PD1L Rights In Certain Breast Cancer(s), This Fall?Unknownnoreply@blogger.comBlogger2125tag:blogger.com,1999:blog-4241416962008169508.post-15717799719244473572015-04-30T20:50:35.338-04:002015-04-30T20:50:35.338-04:00BMY and MRK have melanoma sewn up and will likely ...BMY and MRK have melanoma sewn up and will likely do the same in lung cancer (although others will want to get piece of the lung cancer pie as it is so big). Roche and AZN have already announced their intentions to go after other tumor types to beat BMY and MRK.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-6745859911099439112015-04-30T20:47:27.401-04:002015-04-30T20:47:27.401-04:00Keytruda is an anti-PD-1 mAB, like Opdivo, not an ...Keytruda is an anti-PD-1 mAB, like Opdivo, not an anti-PD-L1 mAB.Anonymousnoreply@blogger.com